Ayumu Matsuda

Chuo, 1040045, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan.

Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan.

Journal: Japanese journal of clinical oncology

Published: October 15, 2025

Comprehensive analysis of oncological outcomes of radical cystectomy for non-muscle invasive bladder cancer.

Comprehensive analysis of oncological outcomes of radical cystectomy for non-muscle invasive bladder cancer.

Journal: Scientific reports

Published: July 07, 2025

Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort.

Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort.

Journal: International journal of clinical oncology

Published: May 14, 2025

Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study.

Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study.

Journal: International journal of clinical oncology

Published: March 13, 2025

Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in Japan.

Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in Japan.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: December 23, 2024

Outcomes of Patients With International Germ Cell Cancer Collaborative Group Good Prognosis Metastatic Seminoma Undergoing De-Escalation Chemotherapy: A Single-Center Retrospective Study.

Outcomes of Patients With International Germ Cell Cancer Collaborative Group Good Prognosis Metastatic Seminoma Undergoing De-Escalation Chemotherapy: A Single-Center Retrospective Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: December 11, 2024

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: August 27, 2024

Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study.

Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study.

Journal: International journal of clinical oncology

Published: August 19, 2024

Widespread benign HNF1β-positive solid nests from the urethral diverticulum to the bladder neck: Is it a mesonephric remnant?

Widespread benign HNF1β-positive solid nests from the urethral diverticulum to the bladder neck: Is it a mesonephric remnant?

Journal: Pathology international

Published: August 06, 2024

Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer.

Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: May 03, 2024

Prognostic impact of histological discordance between transurethral resection and radical cystectomy.

Prognostic impact of histological discordance between transurethral resection and radical cystectomy.

Journal: BJU international

Published: February 12, 2024

Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.

Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.

Journal: Clinical genitourinary cancer

Published: February 05, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026